Yuhan Chemical, a subsidiary of Yuhan Corporation, holds groundbreaking ceremony for new HB building at Hwaseong plant... "Strengthening CDMO Competitiveness"

Groundbreaking ceremony for the new HB building at Yuhan Chemical Hwaseong Plant. [Photo by Yuhan Corporation]

[Asia Economy Reporter Lee Gwan-joo] Yuhan Chemical, a raw material pharmaceutical production subsidiary of Yuhan Corporation, has embarked on expanding its production capacity through the construction of a new production building.

Yuhan Chemical announced on the 4th that it held a groundbreaking ceremony for the HB building at its Hwaseong Plant located in Mado-myeon, Hwaseong-si, Gyeonggi Province.

The new HB building construction project at Yuhan Chemical will cover a total floor area of 9,709.43㎡ and is scheduled for completion by October next year. In his commemorative speech, Seo Sang-hoon, President of Yuhan Chemical, stated, "With the construction of the HB building at the Hwaseong Plant, we will establish production capabilities for a new leap forward in the global CDMO (Contract Development and Manufacturing Organization) business for raw material pharmaceuticals," and emphasized, "We will especially cooperate to ensure the construction is safe and free from disasters."

Yuhan Corporation is actively conducting its CDMO business by supplying chemical synthesis intermediates and APIs (Active Pharmaceutical Ingredients) to global pharmaceutical partners. This is based on the new drug synthesis process and analytical research capabilities of Yuhan Corporation’s Central Research Institute, along with Yuhan Chemical’s production capacity equipped with world-class cGMP production facilities that meet global standards.

Currently, Yuhan Chemical operates two world-class cGMP-grade facilities with a total production capacity of 700,000 liters at Ansan Plant 1 and Hwaseong Plant 2.

This content was produced with the assistance of AI translation services.